Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pancreatic Cancer Stage II”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT00326911
What this trial is testing

Cetuximab and Bevacizumab With or Without Gemcitabine to Treat Metastatic Pancreatic Cancer

Who this might be right for
Metastatic Pancreatic Cancer
Eli Lilly and Company 61
Testing effectiveness (Phase 2)Ended earlyNCT01056601
What this trial is testing

Panobinostat & Bortezomib in Pancreatic Cancer Progressing on Gemcitabine Therapy

Who this might be right for
Pancreatic Cancer
Masonic Cancer Center, University of Minnesota 7
Testing effectiveness (Phase 2)Study completedNCT02005419
What this trial is testing

Metformin Combined With Gemcitabine as Adjuvant Therapy for Pancreatic Cancer After Curative Resection

Who this might be right for
Stage IA Pancreatic AdenocarcinomaStage IB Pancreatic AdenocarcinomaStage IIA Pancreatic Adenocarcinoma+1 more
Xian-Jun Yu 300
Testing effectiveness (Phase 2)WithdrawnNCT02310971
What this trial is testing

Cvac as Maintenance Treatment Patients With Resected Stage I or Stage II Adenocarcinoma (Cancer) of the Pancreas

Who this might be right for
Pancreatic Carcinoma Stage IPancreatic Carcinoma Stage II
Prima BioMed Ltd
Testing effectiveness (Phase 2)UnknownNCT03634332
What this trial is testing

Second-line Study of PEGPH20 and Pembro for HA High Metastatic PDAC

Who this might be right for
Pancreatic Ductal AdenocarcinomaPancreatic CancerPancreatic Neoplasms
Pancreatic Cancer Research Team 35
Testing effectiveness (Phase 2)Ended earlyNCT00416793
What this trial is testing

Bortezomib and Carboplatin in Treating Patients With Metastatic Pancreatic Cancer

Who this might be right for
Acinar Cell Adenocarcinoma of the PancreasDuct Cell Adenocarcinoma of the PancreasStage IV Pancreatic Cancer
National Cancer Institute (NCI) 9
Testing effectiveness (Phase 2)Study completedNCT00534001
What this trial is testing

Bupropion in Helping Adults Stop Smoking

Who this might be right for
Bladder CancerCervical CancerEsophageal Cancer+8 more
Roswell Park Cancer Institute 95
Testing effectiveness (Phase 2)Study completedNCT01658436
What this trial is testing

BEZ235 Phase II Trial in Patients With Advanced Pancreatic Neuroendocrine Tumors (pNET) After Failure of mTOR Inhibitor Therapy.

Who this might be right for
Pancreatic Neuroendocrine Tumors (pNET)
Novartis Pharmaceuticals 31
Early research (Phase 1)UnknownNCT00024063
What this trial is testing

SU006668 in Treating Patients With Advanced Solid Tumors

Who this might be right for
Breast CancerColorectal CancerGastric Cancer+5 more
Jonsson Comprehensive Cancer Center
Testing effectiveness (Phase 2)WithdrawnNCT07026916
What this trial is testing

A Phase II Study to Evaluate GFH375 in Patients With KRAS G12D Mutant Metastatic Pancreatic Cancer

Who this might be right for
Metastatic Pancreatic Cancer
Genfleet Therapeutics (Shanghai) Inc.
Testing effectiveness (Phase 2)Active Not RecruitingNCT04639219
What this trial is testing

T-DXd for the Treatment of Solid Tumors Harboring HER2 Activating Mutations

Who this might be right for
Advanced Solid Tumors With HER2 Mutation,eg:Colorectal,Urothelial,Gastric, Hepatobiliary,Endometrial,Melanoma,Ovarian,Cervical,Salivary Gland,Pancreatic,Breast
AstraZeneca 102
Testing effectiveness (Phase 2)Study completedNCT03699319
What this trial is testing

CPI-613 in Combination With Modified FOLFIRINOX in Locally Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
David Bajor, MD 49
Testing effectiveness (Phase 2)Ended earlyNCT02315625
What this trial is testing

Study of Mutation-Targeted Therapy With Sunitinib or Everolimus in People With Advanced Low- or Intermediate-Grade Neuroendocrine Tumors of the Gastrointestinal Tract and Pancreas With or Without Cytoreductive Surgery

Who this might be right for
Neuroendocrine TumorsNeuroendocrine CarcinomaNeuroendocrine Neoplasms+2 more
National Cancer Institute (NCI) 16
Testing effectiveness (Phase 2)Study completedNCT03225989
What this trial is testing

Trial Investigating an Immunostimulatory Oncolytic Adenovirus for Cancer

Who this might be right for
Pancreatic AdenocarcinomaOvarian CancerBiliary Carcinoma+1 more
Lokon Pharma AB 47
Testing effectiveness (Phase 2)Study completedNCT00617708
What this trial is testing

S0727 Gemcitabine Hydrochloride and Erlotinib Hydrochloride With or Without Monoclonal Antibody Therapy in Treating Patients With Metastatic Pancreatic Cancer That Cannot Be Removed By Surgery

Who this might be right for
Stage IV Pancreatic Cancer
National Cancer Institute (NCI) 134
Testing effectiveness (Phase 2)Study completedNCT00100815
What this trial is testing

Gemcitabine, Capecitabine, and Bevacizumab in Treating Patients With Metastatic or Unresectable Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Roswell Park Cancer Institute 50
Testing effectiveness (Phase 2)Ended earlyNCT05289830
What this trial is testing

Escitalopram to Placebo in Patients With Localized Pancreatic Cancer

Who this might be right for
Pancreatic Ductal AdenocarcinomaPeriampullary Cancer
Case Comprehensive Cancer Center 4
Not applicableLooking for participantsNCT07651358
What this trial is testing

A Tailored, Web-based Program (COMPASS) to Improve Exercise and Dietary Changes in Stage I-III Pancreatic Cancer Patients Receiving Neoadjuvant Chemotherapy

Who this might be right for
Stage I Pancreatic Cancer AJCC v8Stage II Pancreatic Cancer AJCC v8Stage III Pancreatic Cancer AJCC v8
OHSU Knight Cancer Institute 30
Testing effectiveness (Phase 2)UnknownNCT06475326
What this trial is testing

Adebrelimab in Combination With NALIRIFOX in Locally Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Fudan University 87
Testing effectiveness (Phase 2)Study completedNCT00005843
What this trial is testing

R115777 in Treating Patients Who Have Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
National Cancer Institute (NCI) 40
Next Page